Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Bioorg Med Chem Lett ; 17(2): 370-5, 2007 Jan 15.
Article in English | MEDLINE | ID: mdl-17095213

ABSTRACT

Optimisation of ADS100380, a sub-micromolar HDAC inhibitor identified using a virtual screening approach, led to a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids (6a-i), that possessed significant HDAC inhibitory activity. Subsequent functionalisation of the pendent phenyl group of compounds 6f and 6g provided analogues 6j-w with further enhanced enzyme and anti-proliferative activity. Compound 6j demonstrated efficacy in a mouse xenograft experiment.


Subject(s)
Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , Histone Deacetylase Inhibitors , Hydroxamic Acids/chemical synthesis , Hydroxamic Acids/pharmacology , Pyrazoles/chemical synthesis , Pyrazoles/pharmacology , Animals , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacology , Biological Availability , Cell Line, Tumor , Cell Proliferation/drug effects , Computer Simulation , Drug Evaluation, Preclinical , Enzyme Inhibitors/pharmacokinetics , Humans , Indicators and Reagents , Mice , Neoplasm Transplantation , Neoplasms, Experimental/drug therapy , Rats , Structure-Activity Relationship , Transplantation, Heterologous
SELECTION OF CITATIONS
SEARCH DETAIL
...